Site | Total treatment courses n (%) | SBRT | Mixed courses (Boost at the MR-LINAC) | Conventional fractionation exclusively at the MR-Linac |
---|---|---|---|---|
Treatment diagnosis/site; n (%) | 124 | |||
Head and neck | 9 (7) | 0 | 2 | 7 |
Lung | ||||
Mediastinum | 3 (2) | 2 | 0 | 1 |
Lung | 13 (10) | 12 | 0 | 1 |
Abdomen | ||||
Liver | 24 (19) | 19 | 4 | 1 |
Pancreas | 8 (7) | 8 | 0 | 0 |
Abdominal nodes | 8 (7) | 8 | 0 | 0 |
Adrenal gland | 7 (6) | 7 | 0 | 0 |
Kidney | 4 (3) | 4 | 0 | 0 |
Pelvis | ||||
Pelvis | 16 (13) | 13 | 3 | 0 |
Prostate | 18 (15) | 9 | 8 | 1 |
Bone | 10 (8) | 10 | 0 | 0 |
Others (2 cardiac SRS, 1 sarcoma of the limb, 1 peripheral nerve sheath tumor at the lumbar spine) | 4 (3) | 2 | 0 | 2 |